UPDATE 1-Novartis to buy cancer drugmaker Endocyte for $2.1 bln in cash
October 18, 2018 at 02:28 AM EDT
Novartis AG will acquire U.S.-based cancer drugmaker Endocyte Inc for $2.1 billion in cash as the Swiss drugmaker expands its radiopharmaceuticals business, the companies said on Thursday.
